Sir Jon Symonds

Sir Jon Symonds embodies The Steward, a leader defined by fiduciary rigour, institutional continuity and disciplined capital oversight. His career runs through the finance spine of global healthcare, serving as CFO of AstraZeneca and later Novartis before moving into board leadership, including senior roles at HSBC and the chairmanship of Genomics England. As chairman of GSK, he provided steadying governance through the demerger of the consumer health business into Haleon, one of the largest corporate separations in London market history, and backed executive leadership through a period of activist investor pressure. His style is low profile and process driven, prioritising balance sheet strength, board accountability and long horizon science investment over personal visibility. Symonds leads by protecting the institution, ensuring the enterprise outlasts any single strategy, cycle or chief executive.